Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMQ4523)

Drug Name	HU6 DMQ4523
Synonyms	HU6
Drug Type	Small molecule
Structure
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Heart failure with preserved ejection fraction	DISESK0U	BD11.0	Phase 2	[1]
Non-alcoholic steatohepatitis	DIST4788	DB92.1	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT05284617) Exploratory Phase 2A, Double-blind, Placebo-Controlled, Dose Escalation Study to Determine the Safety, Tolerability, PD, and PK of HU6 for the Treatment of Subjects With Obese Heart Failure With Preserved Ejection Fraction (HFpEF). U.S.National Institutes of Health.
2	ClinicalTrials.gov (NCT04874233) A 61-day Randomized, Double Blind, Placebo-controlled Trial to Assess the Safety and Efficacy of Three Doses of HU6 in Subjects With Elevated Liver Fat and High Body Mass Index (28 to 45 kg/m2). U.S.National Institutes of Health.